Obvious Nchimunya Chilyabanyama

12PUBLICATIONS
37CO-AUTHORS
Economic models and forecastingInfant and child healthMajor global burdens of diseaseNutritional epidemiologyElectrical energy generation (incl. renewables, excl. photovoltaics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 15, 2026
Evaluation of plasma anti-CS3 and anti-LTB IgG avidity among Zambian children vaccinated with ETVAX.

|Mar 28, 2024
Application of a Novel Proteomic Microarray Reveals High Exposure to Diarrhoeagenic Escherichia coli among Children in Zambia Participating in a Phase I Clinical Trial.

Kapambwe Mwape, Cynthia Mubanga, Obvious Nchimunya Chilyabanyama

|Nov 25, 2023
Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0-36 Months in Peri-Urban Areas of Lusaka.

Kapambwe Mwape, Samuel Bosomprah, Kennedy Chibesa

|Nov 17, 2023
Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach.

Katayi Mwila-Kazimbaya, Samuel Bosomprah, Obvious Nchimunya Chilyabanyama

|Aug 26, 2023
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia.

Adriace Chauwa, Samuel Bosomprah, Natasha Makabilo Laban

|May 27, 2023
Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX® Vaccine-Induced IgG Antibodies in Zambian Children.

Cynthia Mubanga, Michelo Simuyandi, Kapambwe Mwape

Pageof 2

Frequent Collaborators

6 joint publications

Michelo Simuyandi

5 joint publications

Cynthia Mubanga

3 joint publications

Samuel Bosomprah

2 joint publications

Kennedy Chibesa